Tyme Technologies, Inc. (NASDAQ:TYME) Director Sells $20,312.50 in Stock

Tyme Technologies, Inc. (NASDAQ:TYMEGet Rating) Director Steve Hoffman sold 78,125 shares of Tyme Technologies stock in a transaction dated Tuesday, June 21st. The shares were sold at an average price of $0.26, for a total transaction of $20,312.50. Following the completion of the sale, the director now directly owns 20,100,691 shares in the company, valued at approximately $5,226,179.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Steve Hoffman also recently made the following trade(s):

  • On Wednesday, June 8th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.27, for a total transaction of $21,093.75.
  • On Wednesday, May 25th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.24, for a total transaction of $18,750.00.
  • On Monday, May 9th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.31, for a total transaction of $24,218.75.
  • On Wednesday, April 27th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.32, for a total transaction of $25,000.00.
  • On Monday, April 11th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.31, for a total transaction of $24,218.75.
  • On Monday, March 28th, Steve Hoffman sold 78,125 shares of Tyme Technologies stock. The shares were sold at an average price of $0.34, for a total transaction of $26,562.50.

Shares of NASDAQ:TYME traded up $0.02 during midday trading on Thursday, hitting $0.28. The stock had a trading volume of 637,836 shares, compared to its average volume of 806,536. Tyme Technologies, Inc. has a 1 year low of $0.22 and a 1 year high of $2.02. The stock has a 50 day moving average price of $0.28 and a two-hundred day moving average price of $0.40. The company has a market capitalization of $48.32 million, a PE ratio of -2.04 and a beta of 1.10.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. lifted its stake in shares of Tyme Technologies by 8.7% in the third quarter. BlackRock Inc. now owns 2,084,696 shares of the company’s stock valued at $2,147,000 after purchasing an additional 166,889 shares during the period. GSA Capital Partners LLP acquired a new stake in shares of Tyme Technologies in the fourth quarter valued at about $109,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Tyme Technologies in the third quarter valued at about $571,000. Hedge funds and other institutional investors own 21.00% of the company’s stock.

About Tyme Technologies (Get Rating)

Tyme Technologies, Inc, a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma.

Featured Stories

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.